A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Passage Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,125,574 shares of PASG stock, worth $731,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,125,574
Previous 1,205,524 6.63%
Holding current value
$731,623
Previous $1.63 Million 45.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.79 - $1.58 $63,160 - $126,321
-79,950 Reduced 6.63%
1,125,574 $889,000
Q1 2024

May 13, 2024

SELL
$0.86 - $1.73 $15,331 - $30,840
-17,827 Reduced 1.46%
1,205,524 $1.63 Million
Q4 2023

Feb 13, 2024

BUY
$0.6 - $1.01 $137,371 - $231,241
228,952 Added 23.02%
1,223,351 $1.24 Million
Q3 2023

Nov 14, 2023

BUY
$0.66 - $1.01 $10,100 - $15,457
15,304 Added 1.56%
994,399 $654,000
Q2 2023

Aug 11, 2023

BUY
$0.82 - $1.19 $11,639 - $16,892
14,195 Added 1.47%
979,095 $922,000
Q1 2023

May 12, 2023

SELL
$0.96 - $1.88 $217,200 - $425,350
-226,250 Reduced 18.99%
964,900 $924,000
Q4 2022

Feb 13, 2023

SELL
$1.06 - $1.48 $74,465 - $103,970
-70,250 Reduced 5.57%
1,191,150 $1.64 Million
Q3 2022

Nov 14, 2022

BUY
$1.22 - $2.48 $287,669 - $584,771
235,795 Added 22.99%
1,261,400 $1.58 Million
Q2 2022

Aug 12, 2022

BUY
$1.63 - $3.46 $407,019 - $863,979
249,705 Added 32.18%
1,025,605 $2.42 Million
Q1 2022

May 13, 2022

BUY
$2.66 - $6.49 $798,798 - $1.95 Million
300,300 Added 63.14%
775,900 $2.41 Million
Q4 2021

Feb 11, 2022

BUY
$6.24 - $10.2 $2.14 Million - $3.49 Million
342,400 Added 257.06%
475,600 $3.02 Million
Q3 2021

Nov 12, 2021

BUY
$9.73 - $15.52 $670,397 - $1.07 Million
68,900 Added 107.15%
133,200 $1.33 Million
Q2 2021

Aug 13, 2021

BUY
$12.44 - $19.45 $799,892 - $1.25 Million
64,300 New
64,300 $851,000
Q4 2020

Feb 10, 2021

SELL
$14.28 - $29.73 $359,856 - $749,196
-25,200 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$12.39 - $26.15 $312,228 - $658,980
25,200 New
25,200 $330,000

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $35.4M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.